Current evidence suggests discontinuing GLP-1 medications before attempting conception, though ongoing research continues to define the safest approach for each patient
The pullback is real, its accelerating, and its being driven almost entirely by cost
Providers must review progress, side effects and adherence before adjusting the dose or changing treatment
How to transition safely between semaglutide and tirzepatide Whether you are alternating intentionally or switching due to circumstances, the transition process matters enormously
Reported side effects are rare and generally mild, most commonly limited to injection site irritation (in the case of CJC-1295/Ipamorelin) or transient scalp sensitivity with topical applications
It should be stressed that the beneficial results of the use of statins were equally important to the subjects without metabolic syndrome, compared to the ones with metabolic syndrome, proving that the use of statins may have a crucial effect on the management of patients with a genetic disposition to present with NAFLD/NASH, independently of the presence of metabolic syndrome [20]